- Home
- VSTA vs BNTC Comparison
VSTA vs BNTC Comparison
Compare VSTA & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTA
- BNTC
- Stock Information
- Founded
- VSTA 1966
- BNTC 1995
- Country
- VSTA Brazil
- BNTC United States
- Employees
- VSTA N/A
- BNTC N/A
- Industry
- VSTA Other Consumer Services
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- VSTA Real Estate
- BNTC Health Care
- Exchange
- VSTA Nasdaq
- BNTC Nasdaq
- Market Cap
- VSTA 332.9M
- BNTC 335.5M
- IPO Year
- VSTA 2020
- BNTC N/A
- Fundamental
- Price
- VSTA $4.28
- BNTC $13.24
- Analyst Decision
- VSTA Sell
- BNTC Strong Buy
- Analyst Count
- VSTA 1
- BNTC 5
- Target Price
- VSTA N/A
- BNTC $26.00
- AVG Volume (30 Days)
- VSTA 14.1K
- BNTC 40.8K
- Earning Date
- VSTA 08-06-2025
- BNTC 09-25-2025
- Dividend Yield
- VSTA N/A
- BNTC N/A
- EPS Growth
- VSTA N/A
- BNTC N/A
- EPS
- VSTA 1.09
- BNTC N/A
- Revenue
- VSTA $313,466,268.00
- BNTC N/A
- Revenue This Year
- VSTA $12.29
- BNTC N/A
- Revenue Next Year
- VSTA $11.91
- BNTC N/A
- P/E Ratio
- VSTA $3.94
- BNTC N/A
- Revenue Growth
- VSTA 8.99
- BNTC N/A
- 52 Week Low
- VSTA $1.60
- BNTC $8.06
- 52 Week High
- VSTA $5.49
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- VSTA 56.69
- BNTC 59.72
- Support Level
- VSTA $3.78
- BNTC $12.57
- Resistance Level
- VSTA $4.38
- BNTC $13.33
- Average True Range (ATR)
- VSTA 0.18
- BNTC 0.60
- MACD
- VSTA 0.00
- BNTC 0.10
- Stochastic Oscillator
- VSTA 83.33
- BNTC 95.59
About VSTA Vasta Platform Limited
Vasta Platform Ltd operates as an education company in Brazil, engaged in providing end-to-end educational and digital solutions that cater to all needs of private schools operating in the K-12 educational segment. Its business segments are Content and EdTech Platform, and Digital Platform. The Content and EdTech platform derives its results from educational content solutions through digital and printed content, including textbooks, learning systems and other complementary educational services. The Digital Platform enables private schools to aggregate multiple learning strategies and helps them to focus on education through the Business' physical and digital e-commerce platform and other digital services.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.